Medical Search

Medical News from Wall Street Journal

FDA Appears to Back HIV Drug

May 8, 2012, 9:09 am by Wall Street Journal

The FDA appeared to support the use of a Gilead HIV drug in healthy people to help prevent them from contracting the virus that causes AIDS.


Featured Medical Stories

Fitbit Blaze

Have you seen the latest Fitbit?

Fitbit has come a long way and continues to be the top fitness tracker. And now, it is seen as an eye catching fashion accessory and a fitness bling statement. Fitbit's new Blaze is a tracking device and a fashion statement. It has beautiful design and is packed full of features. Check out this wrist candy and all the cool features it has to offer here >> See the HOTTEST new Fitbit!

See the HOT Fitbit Blaze Now Compare All Fitbit Products Google Fitbit
Matcha Green Tea Super Food Antioxidants

Matcha Green Tea King of Superfoods

Matcha Green Tea is the latest superfood that celebs and regular folk are finding give them supercharged antioxidant purification with a non-jittery sense of focus. Most matcha available to buy is in very small sizes and is not high enough quality. It is important that you buy high quality matcha. We've found bulk high quality 100% natural matcha green tea imported from Japan. Learn more here: Japanese Matcha Green Tea in bulk here on Amazon

High Quality Matcha Find Matcha on Amazon Google Matcha Green Tea

More medical news from Wall Street Journal

Medtronic Revenue Continues to Grow on Acquisition
Wall Street Journal : May 31, 2016, 6:26 am
Medtronic gave a rosy revenue outlook for the year and reported better-than-expected growth in its fourth quarter, helped by its acquisition of Covidien.

Icahn Takes Big Stake in Allergan, Endorses Drugmaker's CEO
Wall Street Journal : May 31, 2016, 5:41 am
Billionaire investor Carl Icahn took a stake in Allergan PLC and threw his support behind the drug company’s chief executive, Brent Saunders, in a departure from the activist’s usual playbook.

FDA Rejects Teva's Application For Huntington's Drug
Wall Street Journal : May 31, 2016, 4:45 am
The Food and Drug Administration rejected a drug application from Teva Pharmaceutical Industries Ltd., asking for more information on the effects of the drug that treats some symptoms of Huntington’s disease.

BioMarin to Stop Developing Kyndrisa
Wall Street Journal : May 31, 2016, 3:22 am
BioMarin Pharmaceutical Inc. will abandon development of an experimental treatment for Duchenne muscular dystrophy and three other related products.

Jazz Pharmaceuticals Nears Deal to Buy Celator for About $1.5 Billion
Wall Street Journal : May 30, 2016, 8:59 am
Jazz Pharmaceuticals is nearing a deal to buy Celator Pharmaceuticals for about $1.5 billion, a huge premium for a company with a promising leukemia drug but no revenue.